Reference standardization and triglyceride interference of a new homogeneous HDL-cholesterol assay compared with a former chemical precipitation assay

Clinical Chemistry

Volumn 44, Issue 4, 1998, Pages 779-789

  Cobbaert, Christa ^a   Zwang, Louwerens ^a   Ceriotti, Ferruccio ^b   Modenese, Annalisa ^b   Cremer, Peter ^c   Herrmann, Wolfgang ^d   Hoss, Gerhard ^e   Jarausch, Jochen ^e   Türk, Regina ^e   März, Winfried ^f   Nauck, Matthias ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; POLYETHYLENE; TRIACYLGLYCEROL;

ACCURACY; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL METABOLISM; CORONARY ARTERY DISEASE; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; STANDARDIZATION;

EID: 15444349654     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.4.779     Document Type: Article

References (20)

1. Lewis B, Assmann G, Tikkanen M, Mancini M, Pometta D. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society, prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutr Metab Cardiovasc Dis 1992;2:113-56.
2. NIH. Consensus Development Panel on Triglyceride. High Density Lipoprotein, and Coronary Heart Disease. JAMA 1993;269:505-10.
3. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
4. Barter PJ, Rye KA. High-density lipoproteins and coronary heart disease. Atherosclerosis 1996;121:1-12.
5. Taskinen MR. Insulin resistance and lipoprotein metabolism [Review]. Curr Opin Lipidol 1995;6:153-60.
6. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992;70: 733-7.
7. Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Romo M, Tenkanen L, et al. The Helsinki Heart Study: central findings and clinical implications. Ann Med 1991;23:155-9.
8. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, Frick MH. Joint effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Am J Cardiol 1992;70:733-7.
9. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel II. JAMA 1993;269:3015-23.
10. Wiebe DA, Warnick GR. Measurement of High-density lipoprotein cholesterol concentration. In: Rifai N, Warnick GR, eds. Laboratory measurement of lipids, lipoproteins and apolipoproteins. Washington, DC: AACC Press, 1994:91-105.
11. Demacker PNM, Vos-Janssen HE, Hijmans AGM, van't Laar A, Janssen AP. Measurement of HDL-cholesterol in serum: comparison of six isolation methods with enzymatic cholesterol analysis. Clin Chem 1980;26:1780-6.
12. Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high-density lipoprotein cholesterol quantification. Clin Chem 1979;25:596-604.
13. Crook D. A survey of biases in the measurement of plasma lipid and lipoprotein concentrations in 32 lipid clinics in the UK. Ann Clin Biochem 1996;33:82-3.
14. Warnick GR, Wood PD for the National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. Clin Chem 1995;41:1427-33.
15. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K. Direct Measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin. Clin Chem 1995;41:717-23.
16. Myers GL, Cooper GR, Henderson LO, Hassemer DJ, Kimberly M. Standardization of lipid and lipoprotein measurements. In: Rifai N, Warnick GR, eds. Laboratory measurement of lipids, lipoproteins and apolipoproteins, Washington, DC: AACC Press, 1994:177-205.
17. Vanderlinde RE, Bowers GN, Jr, Schaffer R, Edwards GC. The National Reference System for Cholesterol. Clin Lab Med 1989; 9:89-104.
18. Hainline A, Jr, Karon J, Lippel K (eds.). Manual of laboratory operations: lipid and lipoprotein analysis, 2nd ed. Bethesda, MD: National Heart, Lung and Blood Institute, Lipid Research Clinics Program. HEW Pub. No. NIH 75-628 (rev.). U.S. Government Printing Office Publication No. 1982-361-132:678.
19. Passing H, Bablok W. A new biomedical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709-20.
20. NCCLS. Tentative Guideline EP5-T. User evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards, June 1984.